NCT05236998View on ClinicalTrials.gov

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

December 21, 2021

Study Completion Date

December 31, 2021

Conditions
Healthy Subjects
Interventions
DRUG

SID1903 (FDC)

Single oral administration of SID1903 (FDC) after an overnight fast

DRUG

Dapagliflozin and Sitagliptin

Single oral administration of Dapagliflozin and Sitagliptin after an overnight fast

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT05236998 - A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter